Poster Abstract Session:
043. Candida Auris: Coming Soon to a Patient Near You
Thursday, October 5, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD


Presentations:
142
Emergence and Spread of Candida auris in New York State
Eleanor H. Adams, MD, MPH; Monica Quinn, RN, MS; Emily Lutterloh, MD, MPH; Karen Southwick, MD, MSc; Jane Greenko, RN, MPH, CIC; Rafael Fernandez, MPH; Rosalie Giardina, BS; Rutvik Patel, MSW; Richard Erazo, BS; Ronald Jean Denis, BS; Elizabeth M. Dufort, MD; Debra S. Blog, MD, MPH
143
Mitigating Candida auris at a Busy Community Hospital: A Quasi-Experimental Near Real-time Approach
Emil Lesho, DO, FACP, FIDSA, FSHEA; Melissa Bronstein, RN, MPA; Jodi McNamara, RN; Megan Callahan, RN; Yoon Kwak, MS; Jean Campbell, PhD; Roberto L. Vargas, MD; Mary Hinkle, M.D.; Edward Walsh, MD, FIDSA
144
Public Health Response to U.S. Cases of Candida auris, a Globally-Emerging, Multidrug-Resistant Yeast, 2013–2017
Sharon Tsay, MD; Rory M. Welsh, PhD; Eleanor H. Adams, MD, MPH; Nancy A. Chow, PhD; Lalitha Gade, M.Pharm; Elizabeth L. Berkow, PhD; Emily Lutterloh, MD, MPH; Monica Quinn, RN, MS; Sudha Chaturvedi, PhD; Rafael Fernandez, MPH; Rosalie Giardina, BS; Jane Greenko, RN, MPH, CIC; Karen Southwick, MD; Janna L. Kerins, VMD, MPH; Stephanie Black, MD, MSc; Sarah K. Kemble, MD; Patricia M. Barrett, MSD; Rebecca Greeley, MPH; Kerri Barton, MPH; Dj Shannon, MPH; Alexander Kallen, MD, MPH; Alicia Shugart, MA; Anastasia P. Litvintseva, PhD; Shawn Lockhart, PhD; Tom Chiller, MD, MPH; Brendan R. Jackson, MD, MPH; Snigdha Vallabhaneni, MD, MPH
145
Assessment of Candida auris response to antifungal drugs using time-kill assays and an animal model
Ronen Ben-Ami, MD; Liat Ashkenazi, MD; Judith Berman, PhD; Nuphar Korolker, MSc; Anna Novikov, MSc
146
Pharmacodynamic Optimization for the Treatment of Invasive Candida auris Infection
Alexander J. Lepak, M.D.; Miao Zhao, MS; Elizabeth Berkow, PhD; Shawn Lockhart, PhD; David R. Andes, M.D., FIDSA
Posters
  • C auris ID Week 2017 V1.pdf (1.2 MB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.